Investing in global measles and rubella elimination is needed to avert deaths and advance health equity.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Measles challenges: global resurgence and factors affecting eradication.Italian journal of pediatrics · 2026
   Review
2. Subacute sclerosing panencephalitis as a re-emerging condition due to low vaccination coverage: a case-series.Italian journal of pediatrics · 2025
   Article
3. Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.Vaccine · 2024
   Article
4. Using multi-tissue transcriptome-wide association study to identify candidate susceptibility genes for respiratory infectious diseases.Frontiers in genetics · 2023
   Article

Corrections and comments

• Comment on
  Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.2022

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as